ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.
ImmunityBio Inc Ordinary Shares -1.69% Pre
ImmunityBio Inc Ordinary Shares IBRX | 3.49 3.49 | -1.69% 0.00% Pre |
ImmunityBio shares are trading higher after Piper Sandler maintained a Neutral rating on the stock and raised its price target from $5 to $6.